SLN
Price
$5.01
Change
+$0.16 (+3.30%)
Updated
Sep 17 closing price
Capitalization
226.72M
61 days until earnings call
TGTX
Price
$32.04
Change
+$0.05 (+0.16%)
Updated
Sep 17 closing price
Capitalization
5.08B
42 days until earnings call
Interact to see
Advertisement

SLN vs TGTX

Header iconSLN vs TGTX Comparison
Open Charts SLN vs TGTXBanner chart's image
Silence Therapeutics
Price$5.01
Change+$0.16 (+3.30%)
Volume$63.5K
Capitalization226.72M
TG Therapeutics
Price$32.04
Change+$0.05 (+0.16%)
Volume$2.13M
Capitalization5.08B
SLN vs TGTX Comparison Chart in %
Loading...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLN vs. TGTX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLN is a StrongBuy and TGTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (SLN: $5.04 vs. TGTX: $32.04)
Brand notoriety: SLN and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLN: 95% vs. TGTX: 91%
Market capitalization -- SLN: $226.72M vs. TGTX: $5.08B
SLN [@Biotechnology] is valued at $226.72M. TGTX’s [@Biotechnology] market capitalization is $5.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLN’s FA Score shows that 1 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • SLN’s FA Score: 1 green, 4 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLN’s TA Score shows that 6 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • SLN’s TA Score: 6 bullish, 4 bearish.
  • TGTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SLN is a better buy in the short-term than TGTX.

Price Growth

SLN (@Biotechnology) experienced а +4.78% price change this week, while TGTX (@Biotechnology) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

SLN is expected to report earnings on Nov 18, 2025.

TGTX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.08B) has a higher market cap than SLN($227M). TGTX YTD gains are higher at: 6.445 vs. SLN (-26.744). TGTX has higher annual earnings (EBITDA): 97.6M vs. SLN (-84.82M). TGTX has more cash in the bank: 252M vs. SLN (114M). SLN has less debt than TGTX: SLN (0) vs TGTX (254M). TGTX has higher revenues than SLN: TGTX (454M) vs SLN (27.2M).
SLNTGTXSLN / TGTX
Capitalization227M5.08B4%
EBITDA-84.82M97.6M-87%
Gain YTD-26.7446.445-415%
P/E RatioN/A84.32-
Revenue27.2M454M6%
Total Cash114M252M45%
Total Debt0254M-
FUNDAMENTALS RATINGS
TGTX: Fundamental Ratings
TGTX
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
36
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLNTGTX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPKRF1.30N/A
N/A
Pepkor Holdings Ltd.
NACB65.00N/A
N/A
NATIONAL CAP BANCORP INC.
SDVKY27.36-0.13
-0.47%
Sandvik AB
RUPRF4.12-0.02
-0.48%
Rupert Resources Ltd.
CBSC0.04N/A
-5.00%
Cardiac Biotech Solutions Inc.

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+3.92%
CLLS - SLN
43%
Loosely correlated
-3.01%
CMVLF - SLN
38%
Loosely correlated
N/A
ABCZF - SLN
36%
Loosely correlated
N/A
ANNX - SLN
36%
Loosely correlated
-4.72%
NGNE - SLN
33%
Loosely correlated
+1.72%
More